Bebi Yassin-Rajkumar

452 total citations
4 papers, 18 citations indexed

About

Bebi Yassin-Rajkumar is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Bebi Yassin-Rajkumar has authored 4 papers receiving a total of 18 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Hepatology and 2 papers in Immunology. Recurrent topics in Bebi Yassin-Rajkumar's work include Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (3 papers) and Immunotherapy and Immune Responses (2 papers). Bebi Yassin-Rajkumar is often cited by papers focused on Hepatitis B Virus Studies (4 papers), Hepatitis C virus research (3 papers) and Immunotherapy and Immune Responses (2 papers). Bebi Yassin-Rajkumar collaborates with scholars based in Canada, Belgium and Israel. Bebi Yassin-Rajkumar's co-authors include David E. Anderson, Johanna N. Spaans, Francisco Díaz‐Mitoma, Jacob Atsmon, Joanne M. Langley, Timo Vesikari, Guillaume Poliquin, Pierre Van Damme, Bruce A. Smith and Soren Gantt and has published in prestigious journals such as Journal of Hepatology, Vaccine and Open Forum Infectious Diseases.

In The Last Decade

Bebi Yassin-Rajkumar

4 papers receiving 17 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bebi Yassin-Rajkumar Canada	3	16	14	7	3	2	4	18
Will Rowe United Kingdom	2	15 0.9×	14 1.0×	5 0.7×	5 1.7×	2 1.0×	2	19
Jacqueline Day Canada	3	18 1.1×	18 1.3×	13 1.9×	2 0.7×	3 1.5×	5	33
Min-Feng Liang China	2	20 1.3×	16 1.1×	10 1.4×	7 2.3×	1 0.5×	6	25
Charles Mbendi Nlombi Democratic Republic of the Congo	3	18 1.1×	13 0.9×	7 1.0×	1 0.3×		4	31
Robert Pleśniak Poland	3	15 0.9×	9 0.6×	9 1.3×	1 0.3×	1 0.5×	10	21
Abel Murillo United States	2	19 1.2×	22 1.6×	7 1.0×		1 0.5×	2	24
Markus Gess United Kingdom	3	17 1.1×	13 0.9×	8 1.1×		1 0.5×	4	25
W.A. Long United States	3	18 1.1×	19 1.4×	4 0.6×		3 1.5×	6	21
Yakup Demir Türkiye	3	12 0.8×	11 0.8×	4 0.6×			9	15
Maria Cássia Mendes Corrêa Brazil	3	14 0.9×	9 0.6×	7 1.0×	2 0.7×	2 1.0×	7	29

Countries citing papers authored by Bebi Yassin-Rajkumar

Since Specialization

Citations

This map shows the geographic impact of Bebi Yassin-Rajkumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bebi Yassin-Rajkumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bebi Yassin-Rajkumar more than expected).

Fields of papers citing papers by Bebi Yassin-Rajkumar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bebi Yassin-Rajkumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bebi Yassin-Rajkumar. The network helps show where Bebi Yassin-Rajkumar may publish in the future.

Co-authorship network of co-authors of Bebi Yassin-Rajkumar

This figure shows the co-authorship network connecting the top 25 collaborators of Bebi Yassin-Rajkumar. A scholar is included among the top collaborators of Bebi Yassin-Rajkumar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bebi Yassin-Rajkumar. Bebi Yassin-Rajkumar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Vesikari, Timo, Joanne M. Langley, Johanna N. Spaans, et al.. (2023). The persistence of seroprotective levels of antibodies after vaccination with PreHevbrio, a 3-antigen hepatitis B vaccine. Vaccine. 41(24). 3584–3588. 9 indexed citations

2.

Atsmon, Jacob, et al.. (2021). Rapid and high seroprotection rates achieved with a tri-antigenic Hepatitis B vaccine in healthy young adults: Results from a Phase IV study. Vaccine. 39(8). 1328–1332. 6 indexed citations

3.

Vesikari, Timo, Joanne M. Langley, Nathan Segall, et al.. (2020). Higher proportion of responders with hepatitis B antibody levels ≥ 100 miu/ml with the trivalent HepB vaccine, Sci-B-Vac, compared to Engerix-B: results from the phase 3 double-blind, randomized study comparing immunogenicity and safety (PROTECT). Journal of Hepatology. 73. S579–S579. 2 indexed citations

4.

Vesikari, Timo, Joanne M. Langley, Bruce R. Smith, et al.. (2019). LB13. Trivalent Hepatitis B (HepB) Vaccine Yields Superior Seroprotection Rates in Adults: Results from the Phase 3 Double-Blind, Randomized Study Comparing Immunogenicity and Safety of a 3-Dose Regimen of Sci-B-Vac™ and Engerix B® (PROTECT). Open Forum Infectious Diseases. 6(Supplement_2). S998–S998. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact